PRO-DEX INC (PDEX) Fundamental Analysis & Valuation

NASDAQ:PDEXUS74265M2052

Current stock price

48.61 USD
-1.38 (-2.76%)
Last:

This PDEX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. PDEX Profitability Analysis

1.1 Basic Checks

  • PDEX had positive earnings in the past year.
  • PDEX had a negative operating cash flow in the past year.
  • Each year in the past 5 years PDEX has been profitable.
  • In multiple years PDEX reported negative operating cash flow during the last 5 years.
PDEX Yearly Net Income VS EBIT VS OCF VS FCFPDEX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M -5M 10M -10M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 17.41%, PDEX belongs to the top of the industry, outperforming 96.83% of the companies in the same industry.
  • PDEX has a better Return On Equity (26.96%) than 96.83% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 16.51%, PDEX belongs to the top of the industry, outperforming 95.24% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for PDEX is above the industry average of 9.31%.
  • The 3 year average ROIC (14.16%) for PDEX is below the current ROIC(16.51%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 17.41%
ROE 26.96%
ROIC 16.51%
ROA(3y)10.79%
ROA(5y)11.4%
ROE(3y)17.93%
ROE(5y)20.5%
ROIC(3y)14.16%
ROIC(5y)12.68%
PDEX Yearly ROA, ROE, ROICPDEX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

1.3 Margins

  • With an excellent Profit Margin value of 15.94%, PDEX belongs to the best of the industry, outperforming 92.06% of the companies in the same industry.
  • PDEX's Profit Margin has declined in the last couple of years.
  • PDEX has a Operating Margin of 15.36%. This is amongst the best in the industry. PDEX outperforms 83.07% of its industry peers.
  • PDEX's Operating Margin has declined in the last couple of years.
  • Looking at the Gross Margin, with a value of 28.09%, PDEX is doing worse than 75.13% of the companies in the same industry.
  • PDEX's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 15.36%
PM (TTM) 15.94%
GM 28.09%
OM growth 3Y9.36%
OM growth 5Y-4.56%
PM growth 3Y7.44%
PM growth 5Y-5.13%
GM growth 3Y-2.11%
GM growth 5Y-4.93%
PDEX Yearly Profit, Operating, Gross MarginsPDEX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

6

2. PDEX Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so PDEX is still creating some value.
  • Compared to 1 year ago, PDEX has less shares outstanding
  • Compared to 5 years ago, PDEX has less shares outstanding
  • The debt/assets ratio for PDEX is higher compared to a year ago.
PDEX Yearly Shares OutstandingPDEX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1M 2M 3M 4M
PDEX Yearly Total Debt VS Total AssetsPDEX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

2.2 Solvency

  • An Altman-Z score of 7.45 indicates that PDEX is not in any danger for bankruptcy at the moment.
  • PDEX has a Altman-Z score of 7.45. This is amongst the best in the industry. PDEX outperforms 84.66% of its industry peers.
  • PDEX has a Debt/Equity ratio of 0.21. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.21, PDEX is in line with its industry, outperforming 57.14% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF N/A
Altman-Z 7.45
ROIC/WACC1.57
WACC10.5%
PDEX Yearly LT Debt VS Equity VS FCFPDEX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M -10M 20M 30M

2.3 Liquidity

  • PDEX has a Current Ratio of 3.73. This indicates that PDEX is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 3.73, PDEX is in the better half of the industry, outperforming 62.43% of the companies in the same industry.
  • PDEX has a Quick Ratio of 2.14. This indicates that PDEX is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 2.14, PDEX is in line with its industry, outperforming 54.50% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.73
Quick Ratio 2.14
PDEX Yearly Current Assets VS Current LiabilitesPDEX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M

4

3. PDEX Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 61.19% over the past year.
  • Measured over the past years, PDEX shows a quite strong growth in Earnings Per Share. The EPS has been growing by 10.96% on average per year.
  • The Revenue has grown by 23.68% in the past year. This is a very strong growth!
  • The Revenue has been growing by 13.84% on average over the past years. This is quite good.
EPS 1Y (TTM)61.19%
EPS 3Y35.1%
EPS 5Y10.96%
EPS Q2Q%8.2%
Revenue 1Y (TTM)23.68%
Revenue growth 3Y16.57%
Revenue growth 5Y13.84%
Sales Q2Q%11.12%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-4.43%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year4.48%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PDEX Yearly Revenue VS EstimatesPDEX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M
PDEX Yearly EPS VS EstimatesPDEX Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2 2.5

4

4. PDEX Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 15.00, the valuation of PDEX can be described as correct.
  • 87.30% of the companies in the same industry are more expensive than PDEX, based on the Price/Earnings ratio.
  • Compared to an average S&P500 Price/Earnings ratio of 25.50, PDEX is valued a bit cheaper.
  • The Price/Forward Earnings ratio is 20.02, which indicates a rather expensive current valuation of PDEX.
  • PDEX's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. PDEX is cheaper than 76.72% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 22.67, PDEX is valued at the same level.
Industry RankSector Rank
PE 15
Fwd PE 20.02
PDEX Price Earnings VS Forward Price EarningsPDEX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • PDEX's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. PDEX is cheaper than 84.66% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 12.72
PDEX Per share dataPDEX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

  • PDEX has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)1.37
EPS Next 2YN/A
EPS Next 3YN/A

0

5. PDEX Dividend Analysis

5.1 Amount

  • No dividends for PDEX!.
Industry RankSector Rank
Dividend Yield 0%

PDEX Fundamentals: All Metrics, Ratios and Statistics

PRO-DEX INC

NASDAQ:PDEX (3/25/2026, 4:30:00 PM)

48.61

-1.38 (-2.76%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)01-29
Earnings (Next)04-29
Inst Owners32.13%
Inst Owner Change-6.03%
Ins Owners36.66%
Ins Owner Change1.68%
Market Cap156.04M
Revenue(TTM)66.59M
Net Income(TTM)11.19M
Analysts82.86
Price Target57.12 (17.51%)
Short Float %11.5%
Short Ratio8.8
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)74.8%
Min EPS beat(2)-24.91%
Max EPS beat(2)174.51%
EPS beat(4)3
Avg EPS beat(4)69.51%
Min EPS beat(4)-24.91%
Max EPS beat(4)174.51%
EPS beat(8)5
Avg EPS beat(8)44.11%
EPS beat(12)7
Avg EPS beat(12)20.2%
EPS beat(16)8
Avg EPS beat(16)16.17%
Revenue beat(2)1
Avg Revenue beat(2)7.28%
Min Revenue beat(2)-4.18%
Max Revenue beat(2)18.74%
Revenue beat(4)2
Avg Revenue beat(4)7.58%
Min Revenue beat(4)-4.18%
Max Revenue beat(4)19.3%
Revenue beat(8)6
Avg Revenue beat(8)12.93%
Revenue beat(12)9
Avg Revenue beat(12)11.32%
Revenue beat(16)12
Avg Revenue beat(16)11.48%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 15
Fwd PE 20.02
P/S 2.22
P/FCF N/A
P/OCF N/A
P/B 3.76
P/tB 3.76
EV/EBITDA 12.72
EPS(TTM)3.24
EY6.67%
EPS(NY)2.43
Fwd EY4.99%
FCF(TTM)-0.68
FCFYN/A
OCF(TTM)-0.39
OCFYN/A
SpS21.88
BVpS12.93
TBVpS12.93
PEG (NY)N/A
PEG (5Y)1.37
Graham Number30.7
Profitability
Industry RankSector Rank
ROA 17.41%
ROE 26.96%
ROCE 21.27%
ROIC 16.51%
ROICexc 20.85%
ROICexgc 20.86%
OM 15.36%
PM (TTM) 15.94%
GM 28.09%
FCFM N/A
ROA(3y)10.79%
ROA(5y)11.4%
ROE(3y)17.93%
ROE(5y)20.5%
ROIC(3y)14.16%
ROIC(5y)12.68%
ROICexc(3y)16.6%
ROICexc(5y)14.6%
ROICexgc(3y)16.62%
ROICexgc(5y)14.63%
ROCE(3y)18.25%
ROCE(5y)16.34%
ROICexgc growth 3Y23.73%
ROICexgc growth 5Y-8.41%
ROICexc growth 3Y23.84%
ROICexc growth 5Y-8.25%
OM growth 3Y9.36%
OM growth 5Y-4.56%
PM growth 3Y7.44%
PM growth 5Y-5.13%
GM growth 3Y-2.11%
GM growth 5Y-4.93%
F-Score6
Asset Turnover1.09
Health
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF N/A
Debt/EBITDA 0.72
Cap/Depr 73.12%
Cap/Sales 1.3%
Interest Coverage 12.57
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.73
Quick Ratio 2.14
Altman-Z 7.45
F-Score6
WACC10.5%
ROIC/WACC1.57
Cap/Depr(3y)99.37%
Cap/Depr(5y)344.26%
Cap/Sales(3y)1.93%
Cap/Sales(5y)6.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)61.19%
EPS 3Y35.1%
EPS 5Y10.96%
EPS Q2Q%8.2%
EPS Next Y-4.43%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)23.68%
Revenue growth 3Y16.57%
Revenue growth 5Y13.84%
Sales Q2Q%11.12%
Revenue Next Year4.48%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y29.16%
EBIT growth 3Y27.48%
EBIT growth 5Y8.65%
EBIT Next Year10.43%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-206.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-142.63%
OCF growth 3YN/A
OCF growth 5YN/A

PRO-DEX INC / PDEX Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for PRO-DEX INC?

ChartMill assigns a fundamental rating of 5 / 10 to PDEX.


What is the valuation status for PDEX stock?

ChartMill assigns a valuation rating of 4 / 10 to PRO-DEX INC (PDEX). This can be considered as Fairly Valued.


Can you provide the profitability details for PRO-DEX INC?

PRO-DEX INC (PDEX) has a profitability rating of 6 / 10.


What is the financial health of PRO-DEX INC (PDEX) stock?

The financial health rating of PRO-DEX INC (PDEX) is 6 / 10.


What is the expected EPS growth for PRO-DEX INC (PDEX) stock?

The Earnings per Share (EPS) of PRO-DEX INC (PDEX) is expected to decline by -4.43% in the next year.